Dow Down 3.39% Nasdaq Down 4.12%

Enzon Pharmaceuticals Inc. (ENZN)

-Other OTC
0.39 Up 0.00(0.08%) Jun 24, 3:42PM EDT
Prev Close:0.39
Open:0.39
Bid:N/A
Ask:N/A
1y Target Est:14.00
Beta:0.808856
Next Earnings Date:N/A
Day's Range:0.39 - 0.40
52wk Range:0.39 - 1.82
Volume:213,622
Avg Vol (3m):331,820
Market Cap:17.35M
P/E (ttm):1.09
EPS (ttm):0.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ENZN

Comparison

Symbol% ChgMkt Cap
ENZNUp 0.08%17.35M
PFEDown 1.79%206.02B
ISIS 0.00%6.91B
NKTRDown 7.46%1.96B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.14
Ex-Dividend Date:30-Dec-15

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Enzon Pharmaceuticals, Inc. engages in licensing drug products. Its marketed drug products include PegIntron for chronic hepatitis C; Sylatron for melanoma; Macugen for neovascular (wet) age-related macular degeneration; and CIMZIA for the treatme... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback